Location History:
- Ramat-Ha-Sharon, IL (1999)
- Ramai-Ha-Sharon, IL (2001)
Company Filing History:
Years Active: 1999-2001
Title: The Innovative Contributions of Mara Hareuveni
Introduction
Mara Hareuveni is a notable inventor based in Ramai-Ha-Sharon, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment and prevention of malignant tumors. With a total of 3 patents to her name, her work is recognized for its potential impact on cancer therapies.
Latest Patents
Hareuveni's latest patents focus on pharmaceutical compositions that utilize recombinant viruses. One of her key inventions involves a pharmaceutical composition for the treatment or prevention of malignant tumors. This composition includes a DNA fragment encoding a polypeptide recognized by the antibody H23, which specifically targets a tumor antigen expressed on breast cancer cells. The antibody binds to an epitope comprising a tandem repeat sequence of 20 amino acids, found in both transmembrane and secreted forms of the polypeptide. Another patent also centers on a similar pharmaceutical composition that employs the same polypeptide recognized by antibody H23, further emphasizing her innovative approach to cancer treatment.
Career Highlights
Mara Hareuveni has established herself as a leading figure in her field through her groundbreaking research and patent filings. Her work at Transgene S.a. has allowed her to explore and develop novel therapeutic strategies for cancer treatment.
Collaborations
Hareuveni has collaborated with esteemed colleagues such as Pierre H Chambon and Marie-Paule Kieny, enhancing her research through shared expertise and innovative ideas.
Conclusion
Mara Hareuveni's contributions to pharmaceutical innovations demonstrate her commitment to advancing cancer treatment. Her patents reflect a deep understanding of the complexities of tumor biology and the potential for targeted therapies.